Arthritis itself is not a direct cause of death, but certain types of arthritis can shorten life expectancy by raising the risk of fatal complications. The distinction matters: osteoarthritis, the most common form, does not significantly increase your overall risk of dying. Rheumatoid arthritis, on the other hand, shortens life expectancy by an average of about 5 years due to its effects on the heart, lungs, and immune system.
Osteoarthritis Does Not Shorten Life
If you have osteoarthritis, the wear-and-tear type that affects knees, hips, and hands, the reassuring answer is that it carries no significant increase in overall mortality. A large meta-analysis of observational studies found no meaningful association between osteoarthritis and all-cause death. There is a modest link to cardiovascular death, but that connection appears to run through indirect pathways: joint pain makes people less active, inactivity contributes to weight gain, and both feed into heart disease risk over time. The arthritis itself is not damaging your organs.
That said, this indirect pathway is worth taking seriously. If osteoarthritis pain keeps you sedentary for years, the downstream effects on heart health, blood sugar, and body weight are real. Staying as physically active as your joints allow is one of the most meaningful things you can do to keep osteoarthritis from affecting your long-term health.
Rheumatoid Arthritis Carries Real Risks
Rheumatoid arthritis (RA) is a different story. It is a systemic autoimmune disease, meaning it does not just attack joints. The chronic inflammation it produces circulates throughout the body and damages blood vessels, lung tissue, and other organs over time. A nationwide study tracking RA patients from diagnosis found that the average loss of life expectancy was 4.97 years compared to matched individuals without RA.
The three leading causes of death in people with RA are the same as in the general population: cardiovascular disease (28.2% of deaths), cancer (24.8%), and respiratory disease (13.2%). What changes is the rate. People with RA develop these conditions more often and at younger ages than they otherwise would.
Why RA Damages the Heart
The connection between RA and heart disease is not just about shared risk factors like smoking or high cholesterol, though those matter too. The same immune cells that attack joint tissue in RA also accelerate the buildup of plaque in arteries. In both RA and heart disease, certain immune cells undergo premature aging and lose their normal controls. These worn-out cells show up inside arterial plaque, where they produce inflammatory signals and directly damage blood vessel walls.
A genetic factor involved in RA susceptibility also independently raises the risk of heart attack, even in people who don’t have arthritis. This suggests a deep biological overlap between the two diseases. Chronic, body-wide inflammation stiffens arteries, promotes clotting, and destabilizes the plaques that cause heart attacks and strokes. For someone with poorly controlled RA, the cardiovascular system is under constant low-grade assault.
Lung Disease as a Complication
About 10% of people with RA develop a serious lung complication called interstitial lung disease, where inflammation causes progressive scarring of lung tissue. This scarring reduces the lungs’ ability to transfer oxygen and can become life-threatening. Among all RA-associated deaths recorded on U.S. death certificates over a 16-year period, roughly 6.6% involved this type of lung disease as a contributing factor, and that proportion has been rising over time, particularly in women.
The scarring tends to develop gradually, often without obvious symptoms in early stages. Unexplained shortness of breath or a persistent dry cough in someone with RA warrants attention, since early detection allows for treatment that can slow the progression.
Medication Risks to Be Aware Of
The drugs used to manage arthritis carry their own risks, though these are generally far smaller than the risks of uncontrolled disease. Long-term use of anti-inflammatory painkillers (NSAIDs) raises the chance of stomach bleeding and ulcers. When bleeding or perforation does occur in someone taking these medications, mortality is significant: roughly 1 in 5 cases are fatal, based on data published since 1997. This does not mean 1 in 5 NSAID users will die. It means that among the small fraction who develop serious gastrointestinal complications, the outcomes can be severe.
Biologic therapies, the more powerful drugs used to suppress the immune system in RA, carry a risk of serious infections. Because these medications dial down immune surveillance, opportunistic infections (particularly certain fungal infections) can become dangerous. Mortality rates from invasive fungal infections in patients on biologics range from 20% to as high as 100% depending on the type of infection, though these events are uncommon. The tradeoff is that untreated RA inflammation causes cumulative organ damage that, over years, poses a greater threat than the medications used to control it.
Juvenile Arthritis and Long-Term Outlook
Children diagnosed with juvenile idiopathic arthritis generally have normal life expectancies. Most forms of childhood arthritis respond well to modern treatments, and the goal of therapy is to prevent long-term disability and allow normal development. The exception is systemic-onset juvenile arthritis, which can produce body-wide inflammation and carries a higher risk of life-threatening complications. Even so, most children with this form do well with current treatments.
Lupus-Related Arthritis
Systemic lupus erythematosus (lupus) frequently causes joint inflammation that looks and feels like arthritis. Lupus is a more aggressive autoimmune disease that can attack the kidneys, brain, and heart. Its survival rates have improved dramatically: 10-year survival is about 98% for people diagnosed before age 50, and around 90% for those diagnosed later. While lupus is more dangerous than RA in some respects, the vast majority of people diagnosed today will live for decades with the disease.
What Actually Determines Risk
For inflammatory types of arthritis, the single biggest factor in long-term survival is how well the underlying inflammation is controlled. Persistent, poorly managed inflammation is what drives the cardiovascular damage, lung scarring, and other complications that shorten life. People with RA who achieve sustained low disease activity have outcomes much closer to the general population than those with ongoing flares.
Other factors that matter include smoking (which worsens both RA activity and cardiovascular risk), maintaining a healthy weight, staying physically active, and managing blood pressure and cholesterol. These are the same things that protect anyone’s heart, but they carry extra weight when your immune system is already putting stress on your blood vessels. The practical bottom line: arthritis is not a death sentence, but the inflammatory forms demand consistent management to prevent the complications that can become one.